"10.1371_journal.pone.0107471","plos one","2014-09-15T00:00:00Z","Nasheeta Peer; Carl Lombard; Krisela Steyn; Nomonde Gwebushe; Naomi Levitt","Non-communicable Diseases Research Unit, Medical Research Council, Durban, South Africa; Chronic Disease Initiative for Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa; Biostatistics Unit, Medical Research Council, Cape Town, South Africa; Division of Endocrinology and Diabetes, Department of Medicine, University of Cape Town, Cape Town, South Africa","Conceived and designed the experiments: NP KS CL NG NL. Analyzed the data: NP CL NG. Contributed to the writing of the manuscript: NP KS CL NL.","The study funders included a commercial source, Servier Laboratories. However, none of the funders had a role in the study design, the analyses and the interpretation of the results, or in writing the article. NL has received honoraria from Novartis for serving on the steering committee for the Navigator Trial and travel support from Novo Nordisk, Eli Lilly Laboratories and Sanofi Aventis. All other authors report no potential conflicts of interest, including specific financial interests, relevant to the subject of this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","09","Nasheeta Peer","NP",5,TRUE,5,NA,3,NA,TRUE,TRUE,FALSE,0,NA,FALSE
